{"id":"https://openalex.org/W2955771065","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-229","title":"Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer","display_name":"Abstract LB-229: Utilizing a novel highly specific sialyl-Tn ELISA as a diagnostic for ovarian cancer","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2955771065","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-229","mag":"2955771065"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-lb-229","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-lb-229","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075844281","display_name":"Linah Al-Alem","orcid":"https://orcid.org/0000-0002-5364-0656","observed_orcids":["https://orcid.org/0000-0002-5364-0656"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linah F. Al-Alem","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046249487","display_name":"Jillian M. Prendergast","orcid":"https://orcid.org/0000-0001-7965-4143","observed_orcids":["https://orcid.org/0000-0001-7965-4143"]},"institutions":[{"id":"https://openalex.org/I4210132299","display_name":"Siamab Therapeutics (United States)","ror":"https://ror.org/046a8r834","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132299"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jillian Prendergast","raw_affiliation_strings":["2Siamab Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Siamab Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210132299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028283777","display_name":"Justin Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132299","display_name":"Siamab Therapeutics (United States)","ror":"https://ror.org/046a8r834","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132299"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Clark","raw_affiliation_strings":["2Siamab Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Siamab Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210132299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014544943","display_name":"Bianca Zarrella","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bianca Zarrella","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081261342","display_name":"Dan Dransfield","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132299","display_name":"Siamab Therapeutics (United States)","ror":"https://ror.org/046a8r834","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132299"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dan Dransfield","raw_affiliation_strings":["2Siamab Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Siamab Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210132299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053081492","display_name":"Whitfield B. Growdon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Whitfield Growdon","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073323475","display_name":"David R. Spriggs","orcid":"https://orcid.org/0000-0003-2174-4992","observed_orcids":["https://orcid.org/0000-0003-2174-4992"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Spriggs","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036063618","display_name":"Eric Lawernce Eisenhauer","orcid":"https://orcid.org/0000-0003-0880-601X","observed_orcids":["https://orcid.org/0000-0003-0880-601X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Eisenhauer","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063291035","display_name":"Jeff Behrens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132299","display_name":"Siamab Therapeutics (United States)","ror":"https://ror.org/046a8r834","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132299"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Behrens","raw_affiliation_strings":["2Siamab Therapeutics, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Siamab Therapeutics, Newton, MA","institution_ids":["https://openalex.org/I4210132299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088371009","display_name":"Bo R. Rueda","orcid":"https://orcid.org/0000-0001-9489-8699","observed_orcids":["https://orcid.org/0000-0001-9489-8699"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bo R. Rueda","raw_affiliation_strings":["1Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"LB","last_page":"229"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.2037000060081482,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/subthalamic-nucleus","display_name":"subthalamic nucleus","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tumor-associated-carbohydrate-antigens","display_name":"tumor-associated carbohydrate antigens","score":0.8289999961853027},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.7450000047683716},{"id":"https://openalex.org/keywords/elisa-assay","display_name":"ELISA assay","score":0.5130000114440918},{"id":"https://openalex.org/keywords/ca125","display_name":"CA125","score":0.8130000233650208},{"id":"https://openalex.org/keywords/diagnostic-accuracy","display_name":"diagnostic accuracy","score":0.5230000019073486},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.8159999847412109},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.7509999871253967},{"id":"https://openalex.org/keywords/tumor-immunohistochemistry","display_name":"tumor immunohistochemistry","score":0.6119999885559082},{"id":"https://openalex.org/keywords/benign-versus-malignant-ovarian-tumors","display_name":"benign versus malignant ovarian tumors","score":0.6340000033378601},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.6930000185966492},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7759591341018677},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6850289702415466},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.6619943380355835},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.6615601778030396},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6202737092971802},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5314722657203674},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5311557054519653},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4779769778251648},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.4733562469482422},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44560515880584717},{"id":"https://openalex.org/C2781447364","wikidata":"https://www.wikidata.org/wiki/Q584992","display_name":"Tumor marker","level":3,"score":0.4129894971847534},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3858136534690857},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22987541556358337},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09897050261497498},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-lb-229","doi":"https://doi.org/10.1158/1538-7445.am2019-lb-229","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-lb-229","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393397090","https://openalex.org/W1866517223","https://openalex.org/W2467698600","https://openalex.org/W1998691061","https://openalex.org/W2883692867","https://openalex.org/W3158995561","https://openalex.org/W1905156984","https://openalex.org/W3025730024","https://openalex.org/W2885662259","https://openalex.org/W2969552369"],"abstract_inverted_index":{"Abstract":[0],"Sialyl-Thomsen-nouveau":[1],"antigen":[2,7],"(STn),":[3],"a":[4,47,50,114,117,133,249,282,422,433,482,489],"tumor-associated":[5],"carbohydrate":[6],"(TACA)":[8],"is":[9,293,382],"elevated":[10,259,275],"in":[11,75,140,295,315,367,378,413,447],"several":[12],"solid":[13],"tumors.":[14,125],"In":[15,126],"ovarian":[16,124,492],"cancer,":[17],"increased":[18],"STn":[19,34,92,103,138,220,229,238,260,278,288,314,328,332,346,362,376,388,401,430,454],"levels":[20,139,276,289,311,347,377,402,431],"correlate":[21],"with":[22,55,90,170,181,223,246,302,308,330,343,353,439],"chemo-resistance":[23],"and":[24,97,111,131,154,176,248,265,305,312,442],"decreased":[25],"suvival.":[26],"Our":[27,143,228],"recent":[28],"studies":[29],"suggest":[30,101,398],"that":[31,87,102,291,348,372,399],"many":[32],"of":[33,63,80,215,234,240,269,277,338,370,407,417,497],"antibodies":[35],"utilized":[36],"previously":[37],"were":[38,189,255,279,349,351],"not":[39,383,386],"as":[40,42,66,106,116,281,488],"specific":[41,52,485],"originally":[43],"proposed":[44],"so":[45],"through":[46],"proprietary":[48],"platform,":[49],"highly":[51,484],"anti-STn":[53],"antibody":[54,65],"high":[56,81,182,303],"binding":[57],"affinity":[58],"was":[59,145,160,271,365],"developed.":[60],"Subsequent":[61],"study":[62],"this":[64,127],"an":[67,85,196,232,237,414],"antibody-drug":[68],"conjugate":[69],"(ADC)":[70],"demonstrated":[71,231],"reduced":[72],"tumor":[73,91,322,356,368,440],"growth":[74],"patient":[76],"derived":[77,166],"xenograft":[78],"models":[79],"grade":[82,183],"serous":[83],"OvCa,":[84],"effect":[86],"positively":[88],"correlated":[89],"levels.":[93],"Collectively,":[94],"these":[95],"findings":[96],"those":[98],"by":[99,323],"others":[100],"might":[104],"serve":[105],"relevant":[107],"OvCa":[108,184],"therapeutic":[109],"target":[110],"could":[112,150],"play":[113],"role":[115],"biomarker":[118,424],"for":[119,425,491,501],"discriminating":[120],"malignant":[121,155,224],"from":[122,167,178,192],"benign":[123,153,171,226],"investigation,":[128],"we":[129,149,204,298],"designed":[130],"optimized":[132],"custom":[134],"ELISA":[135,487],"to":[136,146,217,257,410,451,453],"detect":[137,411],"human":[141],"serum.":[142],"objective":[144],"determine":[147,285],"whether":[148,286],"distinguish":[151],"between":[152],"serum":[156,164,177,327,345,400,429],"samples.":[157],"The":[158],"assay":[159,230],"employed":[161],"on":[162,201],"retrospective":[163],"samples":[165,188,301,307,369],"patients":[168,179,194,245,371],"diagnosed":[169,180],"gynecologic":[172],"disease":[173],"(n":[174,185],"=62)":[175],"=200).":[186],"Serum":[187],"all":[190,387],"collected":[191],"consented":[193],"under":[195,208],"approved":[197],"IRB":[198],"protocol.":[199],"Based":[200],"our":[202],"analysis,":[203],"determined":[205],"the":[206,209,243,262,267,296,339,379,394,405,498],"areas":[207],"receiver":[210],"operating":[211],"characteristic":[212],"curves":[213],"(AUC":[214],"ROC)":[216],"compare":[218],"how":[219],"values":[221],"associated":[222,352],"or":[225],"conditions.":[227],"AUC":[233],"0.74":[235],"at":[236],"value":[239,264],"0.025.":[241],"Of":[242],"8":[244],"malignancy":[247,412],"CA-125":[250,270,408],"<":[251],"35":[252],"mIU/ml,":[253],"6":[254],"found":[256],"have":[258,432],"above":[261],"cutoff":[263],"thus":[266],"sensitivity":[268,406],"significantly":[272],"improved":[273],"if":[274],"integrated":[280],"biomarker.":[283],"To":[284],"circulating":[287],"mirrored":[290],"which":[292,381],"detected":[294],"tumor,":[297],"identified":[299],"15":[300,306],"(STn>0.096)":[304],"low":[309,357,375],"(<0.096)":[310],"assessed":[313],"their":[316],"matching":[317],"formalin":[318],"fixed,":[319],"paraffin":[320],"embedded":[321],"immunohistochemistry":[324],"(IHC).":[325],"Elevated":[326],"corresponded":[329],"positive":[331],"focal":[333,358],"2+,":[334],"3+":[335],"staining":[336,366],"60%":[337],"time":[340],"while":[341],"tumors":[342],"corresponding":[344],"<0.096":[350],"6.7%":[354],"IHC":[355],"0,":[359],"1+":[360],"staining)":[361],"staining.":[363],"There":[364],"had":[373],"relatively":[374],"serum,":[380],"surprising":[384],"since":[385],"glycosylated":[389],"proteins":[390],"are":[391],"shed":[392],"into":[393],"blood.":[395],"These":[396],"data":[397],"may":[403,444],"improve":[404],"alone":[409],"adnexal":[415],"mass":[416],"unknown":[418],"nature":[419],"making":[420],"it":[421],"valuable":[423],"clinical":[426],"triage.":[427],"Additionally,":[428],"significant":[434],"correlation":[435],"(Fisher":[436],"exact":[437],"p<0.01)":[438],"expression":[441],"therefore":[443],"be":[445],"useful":[446],"identifying":[448],"women":[449],"likely":[450],"respond":[452],"targeted":[455],"agents.":[456],"Citation":[457],"Format:":[458],"Linah":[459],"F.":[460],"Al-Alem,":[461],"Jillian":[462],"Prendergast,":[463],"Justin":[464],"Clark,":[465],"Bianca":[466],"Zarrella,":[467],"Dan":[468],"Dransfield,":[469],"Whitfield":[470],"Growdon,":[471],"David":[472],"Spriggs,":[473],"Eric":[474],"Eisenhauer,":[475],"Jeff":[476],"Behrens,":[477],"Bo":[478],"R.":[479],"Rueda.":[480],"Utilizing":[481],"novel":[483],"sialyl-Tn":[486],"diagnostic":[490],"cancer":[493],"[abstract].":[494],"In:":[495],"Proceedings":[496],"American":[499],"Association":[500],"Cancer":[502,516],"Research":[503],"Annual":[504],"Meeting":[505],"2019;":[506],"2019":[507],"Mar":[508],"29-Apr":[509],"3;":[510],"Atlanta,":[511],"GA.":[512],"Philadelphia":[513],"(PA):":[514],"AACR;":[515],"Res":[517],"2019;79(13":[518],"Suppl):Abstract":[519],"nr":[520],"LB-229.":[521]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-07-12T00:00:00"}